Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients With Focal Epilepsy [Phase 2]

View source ↗

Summary

An ongoing Phase 2 study is evaluating safety, tolerability, and efficacy of CB03-154 in adult patients with focal epilepsy. The trial status is NOT_YET_RECRUIT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• CB03-154

Snippet

Sponsor: Shanghai Zhimeng Biopharma, Inc. | Conditions: Focal Epilepsy | Phase 2 | Status: NOT_YET_RECRUITING